IgG2 kappa bispecific antibody

1 Drug classified under this drug class

IgG2 kappa bispecific antibody. Elranatamab 40 mg/ml.
Vial with 44/76 mg  in sol. for SC inj. 40 mg/ml
Step-up doses of 12 mg on day 1 and 32 mg on day 4, followed by a full dose of 76 mg weekly from week 2 to week 24
as monother. for the tmt. of adlts. with relapsed and refractory multiple myeloma, who have received at least 3 prior ther., includ. an immunomodulatory agent, a proteasome inhib., and an anti-CD38 antibody and have demonstr. dis. progress. on the last ther.
C/I: Hypersens.